Learn how Twist Bioscience technology can advance your cell therapy research and development. Twist’s synthetic antibody and T cell receptor (TCR) discovery libraries are built using our proprietary oligo synthesis technology, ensuring complexity, diversity, and quality.

These libraries include highly diverse synthetic naïve scFv and VHH antibody phage display libraries for discovery of targeting domains for CAR-T constructs as well as combinatorically assembled TCR libraries from gene fragments. In this webinar, Twist Bioscience’s CSO Aaron Sato will present several proof-of-concept studies showing how these technologies can be utilized for cell therapies.